| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8736875 | Clinical Microbiology Newsletter | 2017 | 5 Pages | 
Abstract
												Molecular profiling studies have identified potential emerging pathogens, such as Streptococcus anginosus group, that may play a role in cystic fibrosis (CF) lung disease by either directly causing infection or upregulating the virulence factors of classic CF pathogens, such as Pseudomonas aeruginosa. Routine surveillance of CF pathogens using traditional microbiology culture guides treatment and management of CF patients; however, routine CF culture protocols have not been modified to select for, detect, and further determine the role these emerging pathogens play in the progression of CF lung disease.
											Related Topics
												
													Life Sciences
													Immunology and Microbiology
													Applied Microbiology and Biotechnology
												
											Authors
												Emily M. Ph.D., MT(ASCP), 
											